September 19, 2014 11:14 AM ET

Pharmaceuticals

Company Overview of Sirion Therapeutics, Inc.

Company Overview

Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical company, engages in the discovery, development, and commercialization of products for the protection and preservation of eyesight. It develops Durezol, a topical steroid for postoperative inflammation and pain, as well as for uveitis; ganciclovir, a topical antiviral for herpetic keratitis; cyclosporine, a topical immunomodulator for dry eye; fenretinide, an oral vitamin A binding protein antagonist for geographic atrophy associated with dry AMD; and Zirgan, a ganciclovir ophthalmic gel for acute herpetic keratitis. The company was incorporated in 2005 and is based in Tampa, Florida. Sirion Therapeutics, Inc. is a subsidiary ...

3110 Cherry Palm Drive

Suite 340

Tampa, FL 33619

United States

Founded in 2005

Phone:

813-496-7325

Fax:

813-496-7328

Key Executives for Sirion Therapeutics, Inc.

Co-Founder
Age: 54
Co-Founder and Senior Vice President of Business Development
Age: 65
Co-Founder and Senior Vice President of Sales & Marketing
Age: 49
Chief Scientific Officer and Senior Vice President of Discovery Research
Senior Vice President of Drug Development
Age: 56
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Oto Medicine Inc. United States
Omnitura Therapeutics, Inc. United States
Genoa Pharmaceuticals, Inc. United States
Solstice Holdings Inc. United States
Onyx Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sirion Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.